Browsing by Ajou Author

김, 혜진(Kim, Hae Jin) Currently indexed
[School of Medicine / Graduate School of Medicine] - [Endocrinology & Metabolism]

Author IDs

ORCID
-
WOS
-
SCOPUS
-

Showing results 1 to 20 of 126

This table browses all dspace content
Pub YearTitleAuthor(s)
2023Impact of Post-Transplant Diabetes Mellitus on Survival and Cardiovascular Events in Kidney Transplant Recipients김대중, 김혜진, 박범희, 이관우, 전자영, 한승진
2023Association between Low-Density Lipoprotein Cholesterol Level and Cardiovascular Outcomes in Korean Adults: A Nationwide Cohort Study김혜진
2023Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus김혜진
2022Hepatoprotective effects of gemigliptin and empagliflozin in a murine model of diet-induced non-alcoholic fatty liver disease강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정
2022Characteristics and Clinical Course of Diabetes of the Exocrine Pancreas: A Nationwide Population-Based Cohort Study김대중, 김혜진, 이관우, 이나미, 전자영, 한승진
2022Mitochondrial protease ClpP supplementation ameliorates diet-induced NASH in mice강엽, 김혜진, 이관우, 이광, 최성이, 한승진
2022Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study김혜진
2022The Positive Association between Muscle Mass and Bone Status Is Conserved in Men with Diabetes: A Retrospective Cross-Sectional and Longitudinal Study김대중, 김혜진, 정윤석, 최용준, 한승진
2022Empagliflozin Reduces the Progression of Hepatic Fibrosis in a Mouse Model and Inhibits the Activation of Hepatic Stellate Cells via the Hippo Signalling Pathway강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정
2022In Vivo Two-Photon Imaging Analysis of Dynamic Degradation of Hepatic Lipid Droplets in MS-275-Treated Mouse Liver강엽, 곽종영, 김혜진, 이관우, 전자영, 최성이
2022Development and psychometric evaluation of a new brief scale to measure eHealth literacy in people with type 2 diabetes김혜진, 이관우, 이은현
2021Acute glucose shift induces the activation of the nlrp3 inflammasome in thp-1 cells강엽, 김대중, 김혜진, 이관우, 한승진
2021Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated Macrophage via the IKK/NF- κ B, MKK7/JNK, and JAK2/STAT1 Signalling Pathways강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정
2021Visfatin exacerbates hepatic inflammation and fibrosis in a methionine-choline-deficient diet mouse model강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정
2021Risk of Cardiovascular Events and Medical Cost of Dapagliflozin and Dipeptidyl Peptidase-4 Inhibitors김혜진
2021Efficacy and Safety of Switching to Teneligliptin in Patients with Type 2 Diabetes Inadequately Controlled with Dipeptidyl Peptidase-4 Inhibitors: 52-Week Results from a Prospective Observational Study김혜진, 이관우
2020A Class I Histone Deacetylase Inhibitor Attenuates Insulin Resistance and Inflammation in Palmitate-Treated C2C12 Myotubes and Muscle of HF/HFr Diet Mice강엽, 김혜진, 이관우, 전자영, 최성이
2020Comparison of heart failure risk and medical costs between patients with type 2 diabetes mellitus treated with dapagliflozin and dipeptidyl peptidase-4 inhibitors: a nationwide population-based cohort study김혜진
2020Hypoglycemia and Dementia Risk in Older Patients with Type 2 Diabetes Mellitus: A Propensity-Score Matched Analysis of a Population-Based Cohort Study김대중, 김혜진, 문소영, 이관우, 전자영, 한승진
2020Efficacy and Tolerability of Pitavastatin Versus Pitavastatin/Fenofibrate in High-risk Korean Patients with Mixed Dyslipidemia: A Multicenter, Randomized, Double-blinded, Parallel, Therapeutic Confirmatory Clinical Trial김혜진
1 2 3 4 5 6 7

Browse